Nano-radiopharmaceuticals as therapeutic agents.
Ontology highlight
ABSTRACT: In recent years, there has been an increased interest in exploring the potential synergy between nanotechnology and nuclear medicine. The application of radioactive isotopes, commonly referred to as radiopharmaceuticals, is recognized in nuclear medicine for diagnosing and treating various diseases. Unlike conventional pharmaceutical agents, radiopharmaceuticals are designed to work without any pharmacological impact on the body. Nevertheless, the radiation dosage employed in radiopharmaceuticals is often sufficiently high to elicit adverse effects associated with radiation exposure. Exploiting their capacity for selective accumulation on specific organ targets, radiopharmaceuticals have utility in treating diverse disorders. The incorporation of nanosystems may additionally augment the ta
SUBMITTER: Dixit T
PROVIDER: S-EPMC10978739 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA